Diabetes
'Miracle' weight-loss drugs could have reduced health disparities: Instead they got worse
The American Heart Association calls them "game changers."
Apr 22, 2024
0
1
The American Heart Association calls them "game changers."
Apr 22, 2024
0
1
For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA Network Open.
Apr 15, 2024
0
0